This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Sept. 16, 2013 /PRNewswire/ -- BioLight Israeli Life Science Investments Ltd (TASE: BOLT), a unique Biomedical firm engaged in the management and commercialization of technology in cancer diagnostics and ophthalmology, today announced its
September 12th RetailInvestorConferences.com presentation is now available for on-demand viewing.
BioLight's presentation will be available 24/7 for 90 days. Investors may download shareholder materials from the "virtual trade booth" for the next three weeks.
www.retailinvestorconferences.com > click on the red "register/ watch event now" button
About BioLight Israeli Life Sciences Investments Ltd:
BioLight Israeli Life Sciences Investments Ltd. is a unique Biomedical firm engaged in the management and commercialization of technology in cancer diagnostics and ophthalmology. The company was founded in 2005 and as of
April 21, 2011 a group led by Mr.
Israel Makov gained control in the company introducing a new approach of value creation through knowledge synergies (the clusters approach).BioLight is a public company traded on the Tel Aviv Stock Exchange (BOLT).
Since 2010, RetailInvestorConferences.com has been the only monthly virtual investor conference series that provides an interactive forum for presenting companies to meet directly with retail investors using a graphically-enhanced online platform.
Designed to replicate the look and feel of location-based investor conferences, Retail Investor Conferences unites PR Newswire's leading-edge online conferencing and investor communications capabilities with BetterInvesting's extensive retail investor audience network.
SOURCE BioLight Israeli Life Science Investments Ltd